Atossa Genetics +55% after adopting poison pill provision

Atossa Genetics (ATOS +55.4%) surged today, apparently from this morning's announcement of a shareholder rights agreement - however, there haven't been any reports indicating the company has been the subject of takeover interest.

The developer of breast health solutions said the agreement is designed to deter "coercive, unfair, or inadequate takeovers and other abusive tactics."

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs